These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2069389)

  • 1. Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice.
    Filice GA; Pomeroy C
    Antimicrob Agents Chemother; 1991 Apr; 35(4):780-2. PubMed ID: 2069389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of clindamycin and josamycin in experimental Toxoplasma gondii infections].
    Terragna A; Canessa A; Terragna FM; Corradino L
    Minerva Med; 1984 Oct; 75(39):2305-8. PubMed ID: 6504394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ganciclovir on murine cytomegalovirus-induced reactivation of toxoplasma pneumonia.
    Banister S; Pomeroy C
    J Lab Clin Med; 1993 Nov; 122(5):576-80. PubMed ID: 8228576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of ketolides in combination with other drugs to treat experimental toxoplasmosis.
    Araujo FG; Khan AA; Bryskier A; Remington JS
    J Antimicrob Chemother; 1998 Nov; 42(5):665-7. PubMed ID: 9848454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii.
    Djurković-Djaković O; Milenković V; Nikolić A; Bobić B; Grujić J
    J Antimicrob Chemother; 2002 Dec; 50(6):981-7. PubMed ID: 12461021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USE OF CLINDAMYCIN IN PALLAS' CATS [
    Girling SJ; Pizzi R; Naylor AD; Richardson D; Richardson U; Harley J; Cole G; Brown D; Fraser M; Tillman E; Barclay D
    J Zoo Wildl Med; 2020 Mar; 51(1):39-45. PubMed ID: 32212544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment protocol determines the efficacy of clindamycin in acute murine toxoplasmosis.
    Nikolić T; Djurković-Djaković O; Bobić B; Nikolić A; Babić D
    Int J Antimicrob Agents; 1999 Feb; 11(2):145-9. PubMed ID: 10221418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic efficacy of recombinant IL-12, clindamycin alone or in combination against experimental reactivated toxoplasmosis.
    Tawfeek GM; Oteifa NM; Mustafa MA
    J Egypt Soc Parasitol; 2001 Dec; 31(3):853-66. PubMed ID: 11775111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoccidial activity of 2-sulfamoyl-4,4-diaminodiphenylsulfone, sulfadiazine, pyrimethamine and clindamycin in cats infected with Toxoplasma gondii.
    Dubey JP; Yeary RA
    Can Vet J; 1977 Mar; 18(3):51-7. PubMed ID: 858118
    [No Abstract]   [Full Text] [Related]  

  • 10. Clindamycin in a murine model of toxoplasmic encephalitis.
    Hofflin JM; Remington JS
    Antimicrob Agents Chemother; 1987 Apr; 31(4):492-6. PubMed ID: 3606059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus-induced reactivation of Toxoplasma gondii pneumonia in mice: lung lymphocyte phenotypes and suppressor function.
    Pomeroy C; Filice GA; Hitt JA; Jordan MC
    J Infect Dis; 1992 Sep; 166(3):677-81. PubMed ID: 1323625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Guanabenz Combination Therapy against Chronic Toxoplasmosis across Multiple Mouse Strains.
    Martynowicz J; Doggett JS; Sullivan WJ
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32540979
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii.
    Gross U; Pohl F
    Curr Top Microbiol Immunol; 1996; 219():235-45. PubMed ID: 8791704
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment with interleukin 12 in combination with atovaquone or clindamycin significantly increases survival of mice with acute toxoplasmosis.
    Araujo FG; Hunter CA; Remington JS
    Antimicrob Agents Chemother; 1997 Jan; 41(1):188-90. PubMed ID: 8980778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ante-mortem diagnosis, diarrhea, oocyst shedding, treatment, isolation, and genetic typing of Toxoplasma gondii associated with clinical toxoplasmosis in a naturally infected cat.
    Dubey JP; Prowell M
    J Parasitol; 2013 Feb; 99(1):158-60. PubMed ID: 22924914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice.
    Piketty C; Derouin F; Rouveix B; Pocidalo JJ
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1467-72. PubMed ID: 2221854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
    Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
    J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice.
    Jost C; Reiter-Owona I; Liesenfeld O
    Parasitol Res; 2007 Nov; 101(6):1603-9. PubMed ID: 17846793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii.
    Blais J; Tardif C; Chamberland S
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2571-7. PubMed ID: 7509143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondii.
    Araujo FG; Slifer T
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2696-701. PubMed ID: 8593005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.